I60 I61 I62 I63 I64
Conditions
Interventions
Group 1: In addition to conventional rehabilitative therapy, the intervention group receives a 45-minute training session with the Armeo®Spring 5 times a week for three weeks.
Group 2: Patients in the
Sponsors
Lurija Institut Kliniken Schmieder Allensbach
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Ability to give informed consent for the participation in the study 2. Sufficient understanding of instructions 3. Ability to operate the Armeo®Spring 4. first cerebrovascular incident leading to hemiplegia, subacute phase < 3 months following incident 5. Movement of the arm possible if the weight of the arm is carried by a support (at least strength level 2 for shoulderjoint movement) 6. At least 18 years of age
Exclusion criteria
Exclusion criteria: 1. prior history of neurological or psychiatric conditions 2. cognitive impairements that hinder the understanding of the study (e.g. receptive (Wernicke) aphasia, global aphasia, dementia) 3. participants demonstrating insufficient compliance 4. severe apraxia 5. severe neglect-relevant pain symptoms of the affected side of the body (>3 on the visual analoge scale [scale ranging from 0 to 10] 6. epilepsy or previous history of epileptic episodes 7. pregnancy 8. Presence of a [cardiac] pacemaker, implanted medical, electromedical or other devices 9. Presence of metallic and conductive inclusions or implants 10. Participants have tattoos in the head- or neckregions, nicotin patches or cosmetic manipulations of the eyelids (permanent make-up) 11. Participants suffering from claustrophobia 12. Participants with metalic contraceptives such as a contraceptive coil (possibly comprised of copper)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fugl-Meyer Assessment in upper limb (at baseline; Post-test after three weeks; Follow-up after another two weeks). | — |
Secondary
| Measure | Time frame |
|---|---|
| Transcranial magnetic stimulation (single stimuli, cortical silent period (cSP) at stimulation intensity 120% above the individual threshold at baseline and after 3 weeks); Magnetic Resonance Imaging / Functional Magnetic Resonance Imaging (resting state fMRI, structural MRI, diffusion tensor imaging at baseline and after 3 weeks). | — |
Countries
Germany
Contacts
Public ContactAida Sehle
Lurija Institut Kliniken Schmieder Allensbach
Outcome results
None listed